Biocon Biologics
Qais Shabandri has over 15 years of experience in biopharmaceutical process development, with significant roles at Biocon and Biocon Biologics. Currently serving as Senior Manager, Qais has previously held positions including Manager and Associate Manager in Manufacturing Sciences and Technology, where responsibilities involved the development of processes for Insulin and analogs while ensuring economic viability aligned with Biosimilarity requirements. Prior experience at Biocon included roles such as Deputy Manager and Assistant Manager in Manufacturing Sciences and Technology, as well as Principal and Senior Scientist positions, focusing on oral Insulin analogs and protein characteristics. Academic qualifications include an M.Tech in Biotechnology from the Vellore Institute of Technology and a B.E. in Biotechnology from Visvesvaraya Technological University.
This person is not in any teams
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics